Recommended Acceptable Intake Limits for Nitrosamine Drug Substance-Related Impurities

[FDA]

Guidance provides applicants and manufacturers of drugs, including prescription and over-the-counter (OTC) drug products, with a recommended framework for predicting the mutagenic and carcinogenic potential of NDSRIs that could be present in drug products and recommends acceptable intake (AI) limits


Baca selengkapnya di : http://www.fda.gov...